Zydus seeks DCGI approval to undertake clinical trials for monoclonal antibodies cocktail that can ...

Retrieved on: 2021-05-28 14:26:54

Tags for this article:

Click the tags to see associated articles and topics

Zydus seeks DCGI approval to undertake clinical trials for monoclonal antibodies cocktail that can .... View article details on hiswai:

Excerpt

ZRC-3308 (Covimabs) is a cocktail of two anti-SARS-CoV-2 monoclonal antibodies to combat mild COVID 19. • Designed to have a long half-life ...

Article found on: www.zyduscadila.com